|
Titan Biotech Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
364.43 Cr.
|
P/BV
|
2.65
|
Book Value (Rs.)
|
166.49
|
|
52 Week High/Low (Rs.)
|
1018/407
|
FV/ML
|
10/1
|
P/E(X)
|
14.66
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
30.07
|
Div Yield (%)
|
0.45
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 31.53 | 28.12 | 38.20 | 42.71 | 10.40 |
| | | | | | |
| Net CashFlow From Operating Activities | 21.15 | 21.18 | 22.86 | 19.24 | 6.12 |
| Net Cash Used In Investing Activities | -20.30 | -20.73 | -18.78 | -8.08 | -2.21 |
| Net Cash Used From Financing Activities | -2.87 | -2.40 | 6.08 | -7.54 | -3.95 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -2.02 | -1.95 | 10.16 | 3.62 | -0.04 |
| Cash And Cash Equivalents Begin of Year | 4.86 | 6.81 | 5.45 | 1.83 | 1.87 |
| Cash And Cash Equivalents End Of Year | 2.84 | 4.86 | 15.61 | 5.45 | 1.83 |
